[ad_1]
Some 100,000 cancer cases could be prevented in Britain over the next 40 years thanks to a vaccine against the human papillomavirus (HPV), responsible for cancer of the cervix of the uterus, mouth, Anus and bads, British health officials said Tuesday.
Announcing the extension of a vaccination program covering both boys and girls, experts from Public Health England (PHE) said the vaccination plan would prevent about 64,000 cervical cancers and nearly 50,000 non-cervical cancers by 2058.
It would be 50 years after the introduction of the HPV vaccination program in Britain – which started in girls in 2008 – when people vaccinated in adolescence could otherwise start developing related cancers. to HPV, said PHE in a statement.
HPV is a badually transmitted virus linked to more than 99% of cervical cancers, 90% of bad cancers, approximately 70% of badl and vulvar cancers and more than 60% of cancers. penile cancers.
Read also: A health app offers a home-based HPV vaccination service
PHE said that from September this year, boys aged 12 and 13 in Britain will be offered these vaccines as part of a government health program.
Since British girls began receiving the HPV vaccine in 2008, studies have shown that infections by some key types of the virus have decreased by 86% among 16 to 21 year olds in England. A Scottish study also showed that the vaccine had reduced pre-cancerous cervical disease in women by up to 71%.
Robin Weiss, professor of viral oncology at University College London, said the extension of the HPV program "should be a win-win situation".
"The HPV vaccine has had 10 years of success in protecting girls against cervical cancer as women," he said in an e-mailed comment. "It is clear that vaccinated boys will benefit themselves from the absence of penile cancer and anus and a decreased risk of head and neck cancer."
[ad_2]
Source link
